Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 981 entries
View as:

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05181397 Org: User:
Start: 02/22/21 End: 09/01/22 Due: 09/01/23

Prognostic Value of Preoperative 6-Minute Walk Test for Laparoscopic Gastrointestinal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03711526 Org: User:
Start: 01/01/19 End: 03/31/20 Due: 03/31/21

Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)

Phase: N/A Priority: Normal
NCT ID: NCT02243228 Org: User:
Start: 08/31/14 End: 08/31/17 Due: 08/31/18

Study of Iguratimod in Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03023592 Org: User:
Start: 02/28/17 End: 04/30/18 Due: 04/30/19

Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis--a Multicenter Study

Phase: N/A Priority: Normal
NCT ID: NCT05858190 Org: User:
Start: 06/01/23 End: 12/01/26 Due: 12/01/27

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT03042000 Org: User:
Start: 02/28/17 End: 12/31/21 Due: 12/31/22

Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL)

Phase: N/A Priority: Normal
NCT ID: NCT04475328 Org: User:
Start: 10/01/20 End: 07/30/22 Due: 07/30/23

Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT07037472 Org: User:
Start: 01/01/24 End: 12/31/28 Due: 12/31/29

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT02803619 Org: User:
Start: 11/30/13 End: - Due: -

Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT03753815 Org: User:
Start: 11/22/18 End: 12/31/21 Due: 12/31/22

Transmuscular Quadratus Lumborum Block for Postoperative Pain After Laparoscopic Adrenalectomy

Phase: N/A Priority: Normal
NCT ID: NCT03942237 Org: User:
Start: 05/10/19 End: 09/02/19 Due: 09/02/20

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04083014 Org: User:
Start: 08/20/19 End: 03/20/24 Due: 03/20/25

Comparison of Two Techniques of Quadratus Lumborum Block

Phase: N/A Priority: Normal
NCT ID: NCT05001802 Org: User:
Start: 08/20/21 End: 12/01/21 Due: 12/01/22

Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

Phase: N/A Priority: Normal
NCT ID: NCT05170555 Org: User:
Start: 12/01/21 End: 07/01/23 Due: 07/01/24

The Impact of Perioperational Malnutrition on the Cost on Gastroenterological Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00987883 Org: User:
Start: 04/30/09 End: 12/31/09 Due: 12/31/10

A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05981066 Org: User:
Start: 07/10/23 End: 12/31/25 Due: 12/31/26

18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04502303 Org: User:
Start: 09/30/20 End: 09/30/21 Due: 09/30/22

A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL

Phase: N/A Priority: Normal
NCT ID: NCT05883085 Org: User:
Start: 05/01/22 End: 05/01/24 Due: 05/01/25

Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01413828 Org: User:
Start: 05/31/11 End: 08/31/16 Due: 08/31/17

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03895970 Org: User:
Start: 04/20/19 End: 08/01/21 Due: 08/01/22

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

Phase: N/A Priority: Normal
NCT ID: NCT06037213 Org: User:
Start: 08/23/23 End: 01/31/24 Due: 01/31/25

A Model for Drug Concentration Prediction of Vancomycin

Phase: N/A Priority: Normal
NCT ID: NCT06431412 Org: User:
Start: 03/01/24 End: 08/31/24 Due: 08/31/25

Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02987244 Org: User:
Start: 03/31/16 End: 03/31/23 Due: 03/31/24

A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT04916756 Org: User:
Start: 01/16/20 End: 03/25/21 Due: 03/25/22

cfDNA in Diagnosis and Differential Diagnosis of Ovarian Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT04220710 Org: User:
Start: 08/20/19 End: 08/20/20 Due: 08/20/21